Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 4 1

Status

Recruiting 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 1

Conditions

Polycystic Ovary Syndrome 3Papillomavirus Infections 2Vulvar Diseases 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2330Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1782Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 935Prednisone 925Cetuximab 921Lenalidomide 916Trastuzumab 901

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × artenimol × Clear all
NCT06075264 2025-08-14

ART-VIN IIB

Frantz Viral Therapeutics, LLC

Phase 2 Recruiting
27 enrolled
Gynecologic

Vulvar Diseases, Papillomavirus Infections

NCT05555862 2025-05-18

anal HSIL HIV-

Frantz Viral Therapeutics, LLC

Phase 2 Active not recruiting
17 enrolled

Papillomavirus Infections

NCT06417099 2025-04-23

Efficacy of Dihydroartemisinin for Treating PCOS

Shanghai Zhongshan Hospital

Phase 2 Completed
30 enrolled

Polycystic Ovary Syndrome

NCT06842524 2025-04-20

Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome

Shanghai Zhongshan Hospital

Phase 2 Recruiting
150 enrolled

Polycystic Ovary Syndrome

NCT05465135 2024-05-17

The Effect of Dihydroartemisinin in PCOS

Shanghai Zhongshan Hospital

Phase 4 Completed
19 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡